James Mulloy

Title: Innovations by James Mulloy in Cancer Therapeutics

Introduction

James Mulloy is an accomplished inventor based in Cincinnati, OH, known for his significant contributions to the field of cancer therapeutics. With a total of two patents to his name, Mulloy has focused on developing innovative compounds that target cancer cells selectively.

Latest Patents

Mulloy's latest patents include "Hydrogen peroxide-activated compounds as selective anti-cancer therapeutics." This patent describes compounds that are activated in the presence of hydrogen peroxide, making them effective against cancers associated with elevated reactive oxygen species (ROS). Additionally, he holds a patent for "ROS-activated compounds as selective anti-cancer therapeutics," which outlines compounds activated by ROS, also targeting cancers linked to increased ROS levels. Both patents provide methods and pharmaceutical compositions for treating these specific types of cancers.

Career Highlights

Throughout his career, Mulloy has worked with prestigious institutions such as the University of Cincinnati and Cincinnati Children's Hospital Medical Center. His work has been instrumental in advancing the understanding and treatment of cancer through innovative therapeutic approaches.

Collaborations

Some of Mulloy's notable collaborators include Edward J. Merino and Guorui Li, who have contributed to his research and development efforts in the field of cancer therapeutics.

Conclusion

James Mulloy's innovative work in developing selective anti-cancer therapeutics showcases his commitment to improving cancer treatment options. His patents reflect a significant advancement in the fight against cancer, highlighting the importance of targeted therapies in modern medicine.